参考文献/References:
[1]Hindricks G,Potpara T,Dagres N,et al.2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J].European Heart Journal,2021,42(5):373-498[2]Calkins H,Hindricks G,Cappato R,et al.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J].Heart Rhythm,2017,14(10):e275-e444.[3]Yilmaz T,Yilmaz A.Altered platelet morphological parameters in patients with retinal vein occlusion[J].Eur Rev Med Pharmacol Sci,2016,20(10):1934-1939. [4]Zhang Y,Yuan YQ.Value of left atrial diameter with CHA2DS2-VASc score in predicting left atrial/left atrial appendage thrombosis in non-valvular atrial fibrillation[J].Arq Bras Cardiol,2021,116(2):325-331.[5]夏莺,喻杰,王红鸾.D-二聚体结合CHA2DS2-VASc评分对心房颤动左心房血栓的诊断价值研究[J].中国实用内科杂志,2016,36(1):64-67.[6]胡盛寿,高润霖,刘力生.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.[7]Gallagher MM,Hennessy BJ,Edvardsson N,et al.Embolic complications of direct current cardioversion of atrial arrhythmias:association with low intensity of anticoagulation at the time of cardioversion[J].Journal of the American College of Cardiology,2002,40(5):926-933.[8]Ramalingam G,Choi SW,Agarwal S,et al.Complications related to peri-operative transoesophageal echocardiography - a one-year prospective national audit by the Association of Cardiothoracic Anaesthesia and Critical Care[J].Anaesthesia,2020,75(1):21-26.[9]Weitz JI,Fredenburgh JC,Eikelboom JW.A Test in Context:D-Dimer[J].Journal of the American College of Cardiology,2017,70(19):2411-2420.[10]Crawford F,Andras A,Welch K,et al.D-dimer test for excluding the diagnosis of pulmonary embolism[J].Cochrane Database of Systematic Reviews,2016,2016(8):CD010864.[11]Du X,Wang Y.The diagnostic efficacy of cardiac CTA combined with D-dimer assay for the detection of left atrial thrombus in patients with atrial fibrillation[J].American Journal of Emergency Medicine,2019,37(10):1922-1926.[12]Almorad A,Ohanyan A,Pintea Bentea G,et al.D-dimer blood concentrations to exclude left atrial thrombus in patients with atrial fibrillation[J].Heart,2021,107(3):195-200.[13]Enta K,Iwade K,Aosaki M,et al.Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation:prospective five-year follow-up study[J].Cardiol,2004,44(6):223-232.[14]Wan H,Wu S,Yang Y,et al.Plasma fibrin D-dimer and the risk of left atrial thrombus:A systematic review and meta-analysis[J].PLoS One,2017,12(2):e0172272.[15]Lin C,Bao Y,Hua W,et al.Differences in D-dimer blood concentration in atrial fibrillation patients with left atrial thrombus or severe left atrial spontaneous echo contrast[J].Interv Card Electrophysiol,2022,64(2):341-347.[16]Citirik M.Central retinal vein occlusion associated with platelet activation[J].Therapeutic Advances in Ophthalmology,2019,11:2515841419864844.[17]Yang J,Zhou X,Fan X,et al.mTORC1 promotes aging-related venous thrombosis in mice via elevation of platelet volume and activation[J].Blood,2016,128(5):615-624.[18]赵曌,王文强,赵春慧.血小板形态参数、左心耳血流动力学参数与老年非瓣膜性心房颤动患者左心耳血栓形成的关系研究[J].实用心脑肺血管病杂志,2022,30(3):22-27.[19]Lurie A,Wang J,Hinnegan KJ,et al.Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation[J].J Am Coll Cardiol,2021,77(23):2875-2886.[20]刘彤,李广平.非瓣膜病心房颤动对左心房大小的影响[J].中国心血管杂志,2004,9(2):109-112.[21]梁丽明,白树堂,符洪犊.探讨老年非瓣膜性房颤左心房内径与左心房/左心耳血栓的关系[J].中南医学科学杂志,2020,48(5):524-527.
相似文献/References:
[1]姜亦瑶,王 凯,施 超.心肌纤维化引发心房颤动的研究进展[J].医学信息,2018,31(12):28.[doi:10.3969/j.issn.1006-1959.2018.12.010]
JIANG Yi-yao,WANG Kai,SHI Chao.Research Progress of Atrial Fibrillation Caused by Myocardial Fibrosis[J].Journal of Medical Information,2018,31(23):28.[doi:10.3969/j.issn.1006-1959.2018.12.010]
[2]张定欣,林先和.经食道三维超声在房颤二尖瓣结构变化对其
返流程度影响中的应用[J].医学信息,2018,31(12):76.[doi:10.3969/j.issn.1006-1959.2018.12.023]
ZHANG Ding-xin,LIN Xian-he.Application of Transesophageal Three-dimensional Ultrasound in the Influence of Mitral Valve Structure Changes on the Degree of Reflux in Atrial Fibrillation[J].Journal of Medical Information,2018,31(23):76.[doi:10.3969/j.issn.1006-1959.2018.12.023]
[3]王淑娟,林祥灿.血浆NT-proBNP水平与同型半胱氨酸对
糖尿病合并心房颤动的相关性研究[J].医学信息,2018,31(14):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
WANG Shu-juan,LIN Xiang-can.Correlation between Plasma NT-proBNP level and Homocysteine in Patients with Diabetes Mellitus Complicated with Atrial Fibrillation[J].Journal of Medical Information,2018,31(23):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
[4]陶春艳.柔性护理在胺碘酮治疗心房颤动护理中的应用研究[J].医学信息,2018,31(24):154.[doi:10.3969/j.issn.1006-1959.2018.24.046]
TAO Chun-yan.Application of Flexible Nursing in the Treatment of Atrial Fibrillation with Amiodarone[J].Journal of Medical Information,2018,31(23):154.[doi:10.3969/j.issn.1006-1959.2018.24.046]
[5]古俊楠,张牧秋,王建强,等.可穿戴设备在心房颤动诊治中的应用[J].医学信息,2019,32(15):34.[doi:10.3969/j.issn.1006-1959.2019.15.012]
GU Jun-nan,ZHANG Mu-qiu,WANG Jian-qiang,et al.Application of Wearable Devices in the Diagnosis and Treatment of Atrial Fibrillation[J].Journal of Medical Information,2019,32(23):34.[doi:10.3969/j.issn.1006-1959.2019.15.012]
[6]刘 瑜,王建强,古俊楠,等.房颤合并功能性二尖瓣返流研究[J].医学信息,2019,32(15):51.[doi:10.3969/j.issn.1006-1959.2019.15.017]
LIU Yu,WANG Jian-qiang,GU Jun-nan,et al.Study on Atrial Fibrillation Combined with Functional Mitral Regurgitation[J].Journal of Medical Information,2019,32(23):51.[doi:10.3969/j.issn.1006-1959.2019.15.017]
[7]张牧秋,古俊楠,刘 瑜,等.NOACS治疗房颤合并急性冠脉综合征的研究[J].医学信息,2019,32(13):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
ZHANG Mu-qiu,GU Jun-nan,LIU Yu,et al.Study of NOACS in the Treatment of Atrial Fibrillation Complicated with Acute Coronary Syndrome[J].Journal of Medical Information,2019,32(23):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
[8]王建强,刘 瑜,张牧秋,等.房颤伴ACS患者经皮冠状动脉介入术后抗栓研究[J].医学信息,2019,32(14):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
WANG Jian-qiang,LIU Yu,ZHANG Mu-qiu,et al.Study on Antithrombotic after Percutaneous Coronary Intervention in Patients with
Atrial Fibrillation and ACS[J].Journal of Medical Information,2019,32(23):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
[9]朱文书,张理想,游杨杨,等.长链非编码RNA MIAT表达水平与心房颤动导管消融术后复发的关系[J].医学信息,2021,34(04):75.[doi:10.3969/j.issn.1006-1959.2021.04.020]
ZHU Wen-shu,ZHANG Li-xiang,YOU Yang-yang,et al.Relationship Between the Expression Level of Long Non-coding RNA MIAT and Recurrence After Catheter Ablation of Atrial Fibrillation[J].Journal of Medical Information,2021,34(23):75.[doi:10.3969/j.issn.1006-1959.2021.04.020]
[10]马 利,李丽华.aVR导联法在心房颤动伴宽QRS波群心动过速鉴别诊断中的应用[J].医学信息,2022,35(19):142.[doi:10.3969/j.issn.1006-1959.2022.19.041]
MA Li,LI Li-hua.Application of aVR Lead Method in Differential Diagnosis of Atrial Fibrillation with Wide QRS Complex Tachycardia[J].Journal of Medical Information,2022,35(23):142.[doi:10.3969/j.issn.1006-1959.2022.19.041]